Publicacións nas que colabora con María Cristina Olague Micheltorena (28)

2024

  1. Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice

    Viruses, Vol. 16, Núm. 3

  2. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

    EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131

  3. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice

    PLoS Pathogens, Vol. 20, Núm. 5

2023

  1. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  2. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

    Aging Cell, Vol. 22, Núm. 3

2022

  1. Rapid SARS-CoV-2 disinfection on distant surfaces with UV-C: The inactivation is affected by the type of material

    Journal of Photochemistry and Photobiology, Vol. 11

2021

  1. Aav-hdv: An attractive platform for the in vivo study of hdv biology and the mechanism of disease pathogenesis

    Viruses, Vol. 13, Núm. 5

  2. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection

    Biomedicine and Pharmacotherapy, Vol. 137

  3. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

    Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946

2020

  1. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 14, Núm. 1, pp. 123-134

  2. TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection

    JHEP Reports, Vol. 2, Núm. 3

2018

  1. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

    Nature Communications, Vol. 9, Núm. 1

  2. Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))

    Journal of Hepatology

  3. TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway

    ImmunoHorizons, Vol. 2, Núm. 11, pp. 363-376

2017

  1. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

    Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679

2016

  1. Complementary effects of interleukin-15 and alpha interferon induce immunity in hepatitis B virus transgenic mice

    Journal of Virology, Vol. 90, Núm. 19, pp. 8563-8574

  2. Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure

    Oncotarget, Vol. 7, Núm. 31, pp. 49008-49026

2015

  1. A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type i IFN Response

    Journal of Innate Immunity, Vol. 7, pp. 466-481

  2. Chronic exposure to IFNα drives medullar lymphopoiesis towards t-cell differentiation in mice

    Haematologica, Vol. 100, Núm. 8, pp. 1014-1022

  3. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver

    Liver International, Vol. 35, Núm. 4, pp. 1274-1289